Related Experiment Video
Updated: Jun 30, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Incà1, Elisabetta Dal Pont, Vincenza Di Leo
1Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy.
Fecal calprotectin tests can predict clinical relapse in inflammatory bowel disease (IBD) patients. A positive calprotectin level in ulcerative colitis (UC) and colonic Crohn's disease (CD) indicates a higher risk of relapse.
Area of Science:
- Gastroenterology
- Clinical Diagnostics
- Inflammatory Bowel Disease Research
Background:
- Assessing inflammatory bowel disease (IBD) clinical course requires regular evaluations and lab tests.
- Predicting relapse is crucial for effective IBD management.
Purpose of the Study:
- To evaluate the predictive role of fecal calprotectin testing for clinical relapse in IBD patients.
- To determine if calprotectin levels can identify patients at higher risk of relapse.
Main Methods:
- Prospective study of 97 ulcerative colitis (UC) and 65 Crohn's disease (CD) patients in remission.
- Stool samples analyzed for calprotectin, with a cutoff of 130 mg/kg.
- Patients followed for 1 year, with relapse rates analyzed using Kaplan-Meier and log-rank tests.
Main Results:
- Positive calprotectin predicted relapse in UC patients (P=0.000).
- In CD patients, only colonic CD showed a significant correlation between positive calprotectin and relapse (P=0.02).
- Relapse rates were higher in patients with positive calprotectin tests for both UC and colonic CD.
Conclusions:
- Fecal calprotectin measurement is a valuable tool for identifying UC and colonic CD patients at increased risk of clinical relapse.
- This non-invasive test aids in proactive management strategies for IBD patients.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...